Friday, May 31, 2019

Glenmark Pharma wilts 3% on muted Q4 show, CLSA downgrades to sell

Elara Capital which has reduce rating on stock said FY19 operating performance remained weak, given lack of meaningful US sales.

from Moneycontrol http://bit.ly/2Kc5juY

No comments:

Post a Comment

  Finding symbol of isotops by proton and neutron